Background Psychiatric comorbidities are increasingly recognised in demyelinating diseases, yet their frequency and timing in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results